Kjetil Hestdal - Photocure President CEO
| PHO Stock | NOK 53.90 0.10 0.19% |
CEO
Dr. Kjetil Hestdal, M.D., Ph.D. has served as President and Chief Executive Officer of Photocure ASA since January 2005. Prior to that, he held the position of Vice President of Research and Development at the Company from January 1997 until October 2004, and the post of the Company Chief Operating Officer from October 2004 until January 2005. Before joining Photocure, Dr. Hestdal served as the Project ManagerMedical Expert at Sandoz and as Senior Scientist at Rikshospitalet since 2005.
| Age | 55 |
| Tenure | 19 years |
| Professional Marks | Ph.D |
| Phone | (47) 22 06 22 18 |
| Web | www.photocure.no |
Photocure Management Efficiency
The company has return on total asset (ROA) of (0.0309) % which means that it has lost $0.0309 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1567) %, meaning that it generated substantial loss on money invested by shareholders. Photocure's management efficiency ratios could be used to measure how well Photocure manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CEO Age | ||
| Christopher Laska | Telenor ASA | N/A | |
| Alexandra Reich | Telenor ASA | 53 | |
| Ove Fredheim | Telenor ASA | N/A | |
| Sharad Mehrotra | Telenor ASA | N/A | |
| Eldar Saetre | Equinor ASA | 63 | |
| Rune Bjerke | DnB ASA | 58 | |
| Svein Brandtzaeg | Norsk Hydro ASA | 61 | |
| LarsAke Norling | Telenor ASA | 49 | |
| Lars Tellmann | Telenor ASA | 43 | |
| Patrik Hofbauer | Telenor ASA | N/A | |
| Stein Vellan | Telenor ASA | N/A | |
| Petter Furberg | Telenor ASA | 52 | |
| Jesper Hansen | Telenor ASA | N/A | |
| Ingeborg Ofsthus | Telenor ASA | 48 | |
| Albern Murty | Telenor ASA | 47 | |
| Rajeev Sethi | Telenor ASA | N/A | |
| Irfan Khan | Telenor ASA | N/A | |
| Svein Holsether | Yara International ASA | 51 | |
| PetterBorre Furberg | Telenor ASA | 56 | |
| Michael Foley | Telenor ASA | N/A | |
| Jukka Leinonen | Telenor ASA | 57 | |
Management Performance
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0309 |
Photocure Leadership Team
Elected by the shareholders, the Photocure's board of directors comprises two types of representatives: Photocure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Photocure. The board's role is to monitor Photocure's management team and ensure that shareholders' interests are well served. Photocure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Photocure's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kathleen Deardorff, COO | ||
| Jan Egberts, Chairman of the Board | ||
| Tolv Hillestad, Group Controller | ||
| Einar Antonsen, Director | ||
| Patricia Kelly, VP HR | ||
| Jeremy Bahr, Chief Business Officer | ||
| David Moskowitz, Head Relations | ||
| Grete Hogstad, Vice President of Strategic Marketing | ||
| Tove Ringvold, Director | ||
| Anders Neijber, Clinical Affairs | ||
| Geoffrey Coy, VP Operations | ||
| Synne Roine, Director | ||
| Erik Dahl, Chief Officer | ||
| Xavier Yon, Director | ||
| Johanna Holldack, Director | ||
| Kari MD, Head Devel | ||
| Gwen Mellincoff, Director | ||
| Ambaw Bellete, Head of United States Cancer Commercial Operations | ||
| Espen Njastein, Head of Nordic Cancer Commercial Operations | ||
| BenteLill Romoren, Chairman of the Board | ||
| Lars Ronn, Director | ||
| Kjetil Hestdal, President CEO | ||
| Gry Stensrud, VP of Technical Devel. and Operations | ||
| Daniel Schneider, President CEO | ||
| Grannum Sant, Director | ||
| Inger Heglund, Vice President of Research and Development | ||
| Tom Pike, Director |
Photocure Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Photocure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0309 | |||
| Profit Margin | (0.20) % | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | 2.77 B | |||
| Shares Outstanding | 27.11 M | |||
| Shares Owned By Insiders | 2.98 % | |||
| Shares Owned By Institutions | 48.69 % | |||
| Price To Earning | 91.78 X | |||
| Price To Book | 6.33 X |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Photocure using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Photocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Photocure Stock analysis
When running Photocure's price analysis, check to measure Photocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Photocure is operating at the current time. Most of Photocure's value examination focuses on studying past and present price action to predict the probability of Photocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Photocure's price. Additionally, you may evaluate how the addition of Photocure to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |